News & Events

In the news

Clean Mails – May 2023

New equipment for biomanufacturing

Biomanufacturing is a complex process which requires live material, experienced staff, and modern equipment. In order to generate innovative medicine from cells and viruses – inherently variable material, various tools are used to create a stable biomanufacturing environment ensuring reproducibility. An expert CDMO, Naobios increased its biomanufacturing capacity by implementing and qualifying two new Kuhner incubator shakers and one Sartorius bioreactor for process development and GMP purposes.

Save the date !

Congresses 2023: meet our teams!

Teams at Naobios are traveling the world to attend major conferences and congresses within the biotech sector. As leaders of the biopharma field, our mission and our drive at the Clean Biologics group are to remain both reachable and up-to-date with regards to the latest developments and innovations.

Clean Mails – December 2022

Naobios signs a Research License Agreement with Valneva on EB66® cell line.

Naobios today announces the signature of a Research License Agreement with Valneva to assess the EB66® cell line as cell substrate for the evaluation of alternative bioprocess design and new technologies.

Clean Mails – December 2022

Naobios, your partner in the production of Human Viral Challenge Agents

Naobios today announces its investment in the manufacturing of Human Viral Challenge Agents.

Clean Mails – September 2022

Naobios x GenSensor: a partnership for bioprocess optimization

Naobios and GenSensor, two renowned companies of the biopharma sector, have announced a partnership to further advance bioprocess optimization for clinical lots of viral vaccines and vectors. It will allow for enhanced bioprocesses and optimized scale-up.

Press Release

Naobios delivers FluGen Inc’s M2SR influenza vaccine candidate for upcoming clinical trials

Naobios’ development work and GMP manufacturing of vaccine clinical batches enables FluGen to conduct its 2022 clinical trials in the United States.

Clean Mails – May 2022

GMP biomanufacturing in a BSL-3 suite

A GMP biomanufacturing expert, Naobios has worked with numerous viruses requiring specific biocontainment procedures. Our state-of-the-art BSL-3 suite welcome hazardous microbes used for the generation of virus-based therapeutic products.

New webinar

How can customized solutions speed up successful GMP manufacturing?

The next edition of our webinar series will be centred on customised solutions when designing GMP processes to manufacture biologics and will take place on June, 23rd.